Skip to content

The Effects of Riboflavin Photodynamic Therapy after cleaning on teeth and their surrounding structures of patients undergoing braces treatment

Comparative Evaluation of the Effects of Riboflavin Photodynamic Therapy as an Adjunct to Ultrasonic Scaling on Periodontal Health in Orthodontic Patients: A Split-Mouth Randomized Controlled Trial

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/080178
Enrollment
60
Registered
2025-02-10
Start date
Unknown
Completion date
Unknown
Last updated
2025-03-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K051- Chronic gingivitis

Interventions

Intervention1: Riboflavin photodynamic therapy: Riboflavin photodynamic therapy will be performed in experimental group at first visit (T0), after 1 month (T1), 2 months (T2), 3 months (T3), 4 months

Sponsors

Dr Javed Sodawala
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients who can follow specific brushing techniques as instructed by the researcher. Patients undergoing fixed orthodontic treatment from at least 6 months. Patients with Gingival index greater than or equal to 1.1, Plaque index greater than or equal to 1 and Bleeding on probing greater than or equal to 1. Patients without oral lesions. Patients who are willing to sign informed consent (self/parent/guardian).

Exclusion criteria

Exclusion criteria: Individuals with special needs. Patient with adverse oral habits such as smoking, tobacco chewing, nail biting. Patients with systemic conditions like diabetes, immune system disorders, glucose-6-phosphate dehydrogenase deficiency or under drugs like anti-depressants- monoamine oxidase inhibitors (MAOIs), antiseptic mouthwash, corticosteroid or immunosuppressant drugs which affects the gingiva. Patients with history of previous periodontal treatment, antibiotic or anti-inflammatory therapy received in the 3 months immediately prior to treatment or during treatment. Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
1. Gingival Index 2. Plaque Index 3. Pocket Depth 4. Bleeding on ProbingTimepoint: At first visit (T0), after 1 month (T1), 3 months (T3) and 6 months (T6).

Secondary

MeasureTime frame
1. Pain and Discomfort 2. Adverse Effects or Complications 3. Cost-Effectiveness 4. Clinical and demographic differencesTimepoint: At first visit (T0), after 1 month (T1), 3 months (T3) and 6 months (T6).

Countries

India

Contacts

Public ContactDr Javed Sodawala

Sharad Pawar Dental College

ranjitkamble2506@gmail.com9822231975

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026